Letter to the Editor: People living with HIV and NAFLD-A population left behind in the global effort for liver fibrosis screening?

Affiliations

¹ Division of Gastroenterology and Hepatology and Division of Infectious Diseases, McGill University Health Centre, Montreal, Canada.
² Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy.
³ UCL Institute for Liver and Digestive Health, Royal Free Hospital, University College London, UK.
⁴ Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
⁵ Fatty Liver Alliance, Canada.
⁶ Royal Free London, NHS Foundation Trust, London, UK.
⁷ Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, USA.
⁸ Department of Hepatology, APHP Henri-Mondor University Hospital, Creteil, France.
⁹ Department of Medicine, University of California, San Francisco, California, USA.
¹⁰ Division of Digestive Disease, Department of Metabolism, Digestion and Reproduction, Liver Unit, St Mary's Hospital, Imperial College London, UK.
¹¹ University Hospital Bonn, Germany.
¹² University of Modena and Reggio Emilia, Italy.

Comment

Giada Sebastiani et al. Hepatology. 2023.

. 2023 Nov 1;78(5):E87-E88.

doi: 10.1097/HEP.0000000000000465. Epub 2023 May 19.

¹ Division of Gastroenterology and Hepatology and Division of Infectious Diseases, McGill University Health Centre, Montreal, Canada.
² Department of Surgical, Medical, Dental and Morphological Sciences, University of Modena and Reggio Emilia, Italy.
³ UCL Institute for Liver and Digestive Health, Royal Free Hospital, University College London, UK.
⁴ Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
⁵ Fatty Liver Alliance, Canada.
⁶ Royal Free London, NHS Foundation Trust, London, UK.
⁷ Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, USA.
⁸ Department of Hepatology, APHP Henri-Mondor University Hospital, Creteil, France.
⁹ Department of Medicine, University of California, San Francisco, California, USA.
¹⁰ Division of Digestive Disease, Department of Metabolism, Digestion and Reproduction, Liver Unit, St Mary's Hospital, Imperial College London, UK.
¹¹ University Hospital Bonn, Germany.
¹² University of Modena and Reggio Emilia, Italy.

No abstract available

Comment in

Reply: People living with HIV and NAFLD and updated guidance on NAFLD screening.
Rinella ME, Terrault N, Neuschwander-Tetri B, Loomba R. Rinella ME, et al. Hepatology. 2023 Nov 1;78(5):E91-E92. doi: 10.1097/HEP.0000000000000469. Epub 2023 May 22. Hepatology. 2023. PMID: 37203291 No abstract available.

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease.
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R. Rinella ME, et al. Hepatology. 2023 May 1;77(5):1797-1835. doi: 10.1097/HEP.0000000000000323. Epub 2023 Mar 17. Hepatology. 2023. PMID: 36727674 Free PMC article. No abstract available.

1. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797–1835.
1. Guaraldi G, Maurice JB, Marzolini C, Monteith K, Milic J, Tsochatzis E, et al. New drugs for NASH and HIV infection: Great expectations for a great need. Hepatology. 2020;71:1831–1844.
1. Kalligeros M, Vassilopoulos A, Shehadeh F, Vassilopoulos S, Lazaridou I, Mylonakis E, et al. Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;S1542-3565:00028–00029.
1. Ryom L, De Miguel R, Cotter AG, Podlekareva D, Beguelin C, Waalewijn H, et al. Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021. HIV Med. 2022;23:849–858.
1. Lake JE, Overton T, Naggie S, Sulkowski M, Loomba R, Kleiner DE, et al. Expert panel review on nonalcoholic fatty liver disease in persons with human immunodeficiency virus. Clin Gastroenterol Hepatol. 2022;20:256–268.